Scientific Research
Blood Service performs active scientific research. We want to increase biomedical knowledge on our areas of expertise.
Blood donation research
Voluntary blood donors are at the core of all blood banking in Finland. FRCBS takes care of our donors in many ways, also through scientific research.
Show more
Blood cell research
Studies on red cells and platelets and on blood products derived from these cells are natural part in the Blood Service R&D portfolio.
Show more
Transplantation Genomics
The research of the blood transfusion, cell, and tissue transplant compatibility serves as the scientific basis shared by all the Blood Service's laboratories.
Show more
Cell therapy
The focus of our cell therapy research lies in translational cell therapy research, the biology of mesenchymal stromal/stem cells and novel immunotherapies.
Show moreNews
The Blood Service names Minna Mäki director of research and product development
Minna Mäki (PhD) has been named director of research, product development and new services at the Blood Service. She takes up her new position on 22 May 2023.
FRCBS Annual Report for 2022 published
The Blood Service Annual Report for 2022 has been published. You will find all the key figures and statistics concerning Finnish Red Cross Blood Service and an overview of the most important changes and events that took place last year.
Applications invited for Blood Service research grants 2023
Call for applications for grants of the Blood Service Research Fund opens on 6 February 2023. The primary aim of the Fund is to support research related to the current and possible future products and services of the Finnish Red Cross Blood Service. The application period is from 6 February to 31 March 2023.
75 years of care: Blood Service celebrates its anniversary
Year 2023 marks the 75th anniversary of the start of operations of Finnish Red Cross Blood Service. The systemic collection of blood began in Finland during the war years. Established in 1948, the Blood Service has been responsible for the national blood supply chain with voluntary donors for decades, for the benefit of the patients.